The CLEAR framework helps guide pharmacists during the process of assessing and delabeling β-lactam allergies to improve patient outcomes.
Cara Slaton, PharmD, BCIDP
Advertisement
Articles by Cara Slaton, PharmD, BCIDP
Delivery, manufacturing concerns hinder green light from US Agency, but European Medicines Agency approves treatment.
Advertisement
Latest Updated Articles
Bulevirtide Shows Promise for Hepatitis D, Despite No FDA ApprovalPublished: May 19th 2023 | Updated:
CLEAR-ing Penicillin and Cephalosporin AllergiesPublished: November 14th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Reformulated Ranitidine After 5-Year Absence
2
Fun Fact: Coffee Could Reduce Feelings of Depression
3
Updated Hypertension Guidelines Are Here
4
Application of the Age-Friendly 4M’s Movement Across Different Areas of Pharmacy
5
